Liberalization of the Indian Pharmaceutical Market and Affordability of Medicines: A Citizen’s Perspective

Summary: This essay examines the liberalization of the Indian pharmaceutical market and its impact on medicine affordability. Despite India’s role as a major global drug producer, the prevalence of expensive branded generics has led to high out-ofpocket expenditures for healthcare. The essay critiques the limited governmental regulation of medicine prices and calls for stronger interventions to promote affordable, unbranded generics, thus addressing the persistent issues in medicine accessibility and cost.

Read and download the full essay here.